Search

Search Constraints

You searched for: Author/Creator Bareggi, Claudia

Search Results

2. Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences. (October 2022)

3. Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice. Issue 2 (5th November 2020)

4. LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial. Issue 3 (27th May 2020)

5. LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial. Issue 3 (27th May 2020)

6. O32-2 Micrornas in blood as biomarker of pleural malignant mesothelioma. (1st September 2016)

7. Pharmacotherapeutic advances with anaplastic lymphoma kinase inhibitors for the treatment of non-small cell lung cancer. (23rd May 2020)

8. Pharmacotherapeutic advances with anaplastic lymphoma kinase inhibitors for the treatment of non-small cell lung cancer. (23rd May 2020)

9. Predictive ability of a drug-based score in patients with advanced non–small-cell lung cancer receiving first-line immunotherapy. (June 2021)

10. Secondary Breast Angiosarcoma and Paclitaxel-dependent Prolonged Disease Control: Report of Two Cases and Review of the Literature. Issue 2 (March 2015)